EPIGENESIS Trademark

Trademark Overview


On Wednesday, August 16, 2000, a trademark application was filed for EPIGENESIS with the United States Patent and Trademark Office. The USPTO has given the EPIGENESIS trademark a serial number of 76113581. The federal status of this trademark filing is ABANDONED - NO STATEMENT OF USE FILED as of Sunday, January 8, 2006. This trademark is owned by EPIGENESIS Pharmaceuticals, Inc.. The EPIGENESIS trademark is filed in the Pharmaceutical Products category with the following description:

Medical, diagnostic and therapeutic preparations and devices for administering same, sold filled, with diagnostic and therapeutic preparations, all for administration via diverse routes of administration, including through the respiratory airways, and medical devices for administering the pharmaceuticals, sold filled, the preparations including nucleotides, proteins and organic molecules for medical use, including macromolecules such as anti-sense oligonucleotides and enzymes and small organic and inorganic molecules for treatment of human and non-human animal respiratory, central nervous system, neoplastic, endocrine, immune and cardiovascular ailments, including bronchoconstriction, difficult breathing, impeded and obstructed lung airways, allergy(ies) and/or inflammation, which in some cases are adenosine receptor associated symptoms, pharmaceutical preparations for testing and preventing and therapeutically treating respiratory, airway and pulmonary diseases and conditions, such as...
epigenesis

General Information


Serial Number76113581
Word MarkEPIGENESIS
Filing DateWednesday, August 16, 2000
Status606 - ABANDONED - NO STATEMENT OF USE FILED
Status DateSunday, January 8, 2006
Registration Number0000000
Registration DateNOT AVAILABLE
Mark Drawing1000 - Typeset: Word(s) / letter(s) / number(s)
Published for Opposition DateTuesday, October 15, 2002

Trademark Statements


Goods and ServicesMedical, diagnostic and therapeutic preparations and devices for administering same, sold filled, with diagnostic and therapeutic preparations, all for administration via diverse routes of administration, including through the respiratory airways, and medical devices for administering the pharmaceuticals, sold filled, the preparations including nucleotides, proteins and organic molecules for medical use, including macromolecules such as anti-sense oligonucleotides and enzymes and small organic and inorganic molecules for treatment of human and non-human animal respiratory, central nervous system, neoplastic, endocrine, immune and cardiovascular ailments, including bronchoconstriction, difficult breathing, impeded and obstructed lung airways, allergy(ies) and/or inflammation, which in some cases are adenosine receptor associated symptoms, pharmaceutical preparations for testing and preventing and therapeutically treating respiratory, airway and pulmonary diseases and conditions, such as asthma, pulmonary vasoconstriction, inflammation, allergies, impeded respiration, Acute Respiratory Distress Syndrome (ARDS), renal damage and failure, ischemia, resulting from the administration of certain drugs, including adenosine and other drugs for, for example, treating SupraVentricular Tachycardia (SVT), adenosine stress tests, infantile Respiratory Distress Syndrome (infantile RDS), pain, cystic fibrosis, allergic rhinitis, allergic bronchitis, pulmonary hypertension, pulmonary vasoconstriction, emphysema, chronic obstructive pulmonary disease (COPD), as well as cancers including leukemias, lymphomas, carcinomas, and the like, eg colon cancer, breast cancer, lung cancer, pancreatic cancer, hepatocellular carcinoma, kidney cancer, melanoma, etc, as well as all metastatic cancers, eg

Classification Information


International Class005 - Pharmaceutical and veterinary preparations; sanitary preparations for medical purposes; dietetic substances adapted for medical use, food for babies; plasters, materials for dressings; material for stopping teeth, dental wax; disinfectants; preparations for destroying vermin; fungicides, herbicides.
US Class Codes006, 018, 044, 046, 051, 052
Class Status Code6 - Active
Class Status DateFriday, September 22, 2000
Primary Code005
First Use Anywhere DateNOT AVAILABLE
First Use In Commerce DateNOT AVAILABLE

Trademark Owner History


Party NameEPIGENESIS PHARMACEUTICALS LLC
Party Type22 - New Owner After Publication
Legal Entity Type03 - Corporation
AddressCRANBURY, NJ 08512

Party NameEPIGENESIS PHARMACEUTICALS, INC.
Party Type21 - New Owner After Publication
Legal Entity Type03 - Corporation
AddressCRANBURY, NJ 08512

Party NameEPIGENESIS Pharmaceuticals, Inc.
Party Type20 - Owner at Publication
Legal Entity Type03 - Corporation
AddressCranbury, NJ 08512

Party NameEPIGENESIS Pharmaceuticals, Inc.
Party Type10 - Original Applicant
Legal Entity Type03 - Corporation
AddressCranbury, NJ 08512

Trademark Events


Event DateEvent Description
Tuesday, March 14, 2006ABANDONMENT NOTICE MAILED - NO USE STATEMENT FILED
Tuesday, March 14, 2006ABANDONMENT - NO USE STATEMENT FILED
Friday, July 1, 2005EXTENSION 5 GRANTED
Friday, July 1, 2005EXTENSION 5 FILED
Friday, July 1, 2005TEAS EXTENSION RECEIVED
Monday, January 10, 2005EXTENSION 4 GRANTED
Thursday, December 23, 2004EXTENSION 4 FILED
Thursday, December 23, 2004TEAS EXTENSION RECEIVED
Friday, July 30, 2004EXTENSION 3 GRANTED
Tuesday, July 6, 2004EXTENSION 3 FILED
Friday, July 16, 2004PAPER RECEIVED
Monday, July 19, 2004TEAS CHANGE OF CORRESPONDENCE RECEIVED
Tuesday, July 13, 2004CASE FILE IN TICRS
Tuesday, July 6, 2004TEAS EXTENSION RECEIVED
Wednesday, January 7, 2004EXTENSION 2 GRANTED
Wednesday, January 7, 2004EXTENSION 2 FILED
Wednesday, January 7, 2004TEAS EXTENSION RECEIVED
Wednesday, July 9, 2003EXTENSION 1 GRANTED
Thursday, July 3, 2003EXTENSION 1 FILED
Thursday, July 3, 2003TEAS EXTENSION RECEIVED
Tuesday, January 7, 2003NOA MAILED - SOU REQUIRED FROM APPLICANT
Tuesday, October 15, 2002PUBLISHED FOR OPPOSITION
Wednesday, September 25, 2002NOTICE OF PUBLICATION
Monday, July 15, 2002APPROVED FOR PUB - PRINCIPAL REGISTER
Friday, May 10, 2002SEC. 1(A) CLAIM DELETED
Friday, May 10, 2002Sec. 1(B) CLAIM ADDED
Friday, May 10, 2002CORRESPONDENCE RECEIVED IN LAW OFFICE
Thursday, November 29, 2001FINAL REFUSAL MAILED
Friday, August 17, 2001CORRESPONDENCE RECEIVED IN LAW OFFICE
Monday, February 12, 2001NON-FINAL ACTION MAILED